Chest Computed Tomography (CT) Screening Study With Antibody Testing

This study has been withdrawn prior to enrollment.
(Due to lack of funding)
Sponsor:
Information provided by:
Mayo Clinic
ClinicalTrials.gov Identifier:
NCT01203579
First received: September 15, 2010
Last updated: June 20, 2012
Last verified: June 2012
  Purpose

The purpose of this study is to assess the value of EarlyCDT-Lung test and CT scan both in lung cancer detection and potential health economic outcomes.


Condition
Lung Cancer

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Different Strategies Using Autoantibodies and/or CT in the Detection of Lung Cancer

Resource links provided by NLM:


Further study details as provided by Mayo Clinic:

Enrollment: 0
Study Start Date: September 2011
Study Completion Date: September 2011
Primary Completion Date: September 2011 (Final data collection date for primary outcome measure)
Detailed Description:

EarlyCDT-Lung test and CT scan both for lung cancer detection and potential economic outcomes.

  Eligibility

Ages Eligible for Study:   50 Years to 75 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population

Current or Former Smokers with >20 pack year history and or family history of lung cancer. Ages 50-75 years old

Criteria
  • Persons 50-75
  • Asymptomatic for lung cancer
  • Current or former (stopped smoking less than 10 years ago) cigarette smokers
  • History of cigarette smoking of at least 20 pack years
  • History of cigarette smoking with a family history of lung cancer which gives an individual a personal risk similar to a smoking history of 20 pk/years (i.e. 1% at 5 years).
  • Mentally competent individuals to sign an informed consent.
  • Healthy enough to undergo pulmonary resection or stereotactic body radiotherapy.
  • A fully informed signed consent form must have been obtained.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01203579

Locations
United States, Minnesota
Mayo Clinic in Rochester
Rochester, Minnesota, United States, 55905
Sponsors and Collaborators
Mayo Clinic
Investigators
Principal Investigator: David Midthun, MD Mayo Clinic
  More Information

No publications provided

Responsible Party: David Midthun, MD, Mayo Clinic
ClinicalTrials.gov Identifier: NCT01203579     History of Changes
Other Study ID Numbers: 10-003048
Study First Received: September 15, 2010
Last Updated: June 20, 2012
Health Authority: United States: Institutional Review Board

Keywords provided by Mayo Clinic:
CDT-Lung,CT scan,lung cancer detection

Additional relevant MeSH terms:
Lung Neoplasms
Respiratory Tract Neoplasms
Thoracic Neoplasms
Neoplasms by Site
Neoplasms
Lung Diseases
Respiratory Tract Diseases

ClinicalTrials.gov processed this record on April 17, 2014